Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Czech Republic

Zentiva's Net Income Rises 16.4% In 2005

March 2006 | Company Finance Alert

Czech pharmaceuticals, cosmetics and food supplement group Zentiva has released financial results for 2005, in which net income was CZK1.84bn (US$77.6mn), up 16.4% from the previous year. Sales were CZK11.8bn (US$497.5mn), a 10.9% increase on the 2004 figure of CZK10.6bn (US$446.8mn).

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries